MedPath

Weight-loss drug Wegovy cuts heart attack risk in people with obesity, study shows

Wegovy, a weight-loss drug, reduces heart attack risk by 20% in obese individuals with heart disease history, showcasing health benefits beyond weight loss. Despite high costs and limited insurance coverage, experts see potential for broader acceptance and treatment of obesity as a serious illness.


Reference News

Weight-loss drug Wegovy cuts heart attack risk in people with obesity, study shows

Wegovy, a weight-loss drug, reduces heart attack risk by 20% in obese individuals with heart disease history, showcasing health benefits beyond weight loss. Despite high costs and limited insurance coverage, experts see potential for broader acceptance and treatment of obesity as a serious illness.

© Copyright 2025. All Rights Reserved by MedPath